Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

News

Ripple taps BNY Mellon, $50 trillion asset manager

Digest more
The Currency Analytics · 5h
XRP Surges as Ripple Picks BNY Mellon to Custody $500M Stablecoin Reserves
Ripple CEO urges U.S. lawmakers to clarify XRP regulation as BNY Mellon joins Ripple to custody RLUSD stablecoin reserves for institutional clients.

Continue reading

 · 2d · on MSN
BNY Mellon will have custody of Ripple's new stablecoin as institutional interest in crypto swells
Cryptopolitan on MSN · 2d
Ripple taps BNY Mellon, $50 trillion asset manager for RLUSD reserves custody
Cryptopolitan on MSN3h
Ripple wraps up drought insurance pilot in Kenya, issues women RLUSD
Ripple concludes blockchain-based drought insurance pilot in Kenya, insuring 517 pastoralists using RLUSD stablecoin.
The Manila Times
13h
Ripple partners with Bank of New York Mellon, XRP soars - LET Mining launches new cloud mining strategy for XRP holders
Driven by this wave of compliance benefits and market enthusiasm, the green cloud mining platform LET Mining responded ...
1d
XRP 'finally breaking out' with 12% rally after Ripple-BNY Mellon deal
Bullish chart setups hint at more upside for XRP, with price targets near $2.87 and possibly $3.72 if momentum holds.
The Daily Hodl
1d
Ripple Partners With BNY Mellon As CEO Brad Garlinghouse Predicts ‘a Lot of Growth’ for Crypto Industry
Ripple has announced it will be working with banking giant BNY Mellon to custody its proprietary stablecoin, RLUSD.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy